Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/12892
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRada, Elsa-
dc.contributor.authorUlrich, Mariam-
dc.contributor.authorAranzazu, Nacarid-
dc.contributor.authorSantaella, Carlos-
dc.contributor.authorGallinoto, Maria Eugenia-
dc.contributor.authorCenteno, Marta-
dc.contributor.authorRodriguez, Vestalia-
dc.contributor.authorConvit, Jacinto-
dc.date.accessioned2015-11-24T16:58:44Z-
dc.date.available2015-11-24T16:58:44Z-
dc.date.issued1994-07-28-
dc.identifier.urihttp://hdl.handle.net/10872/12892-
dc.description.abstractIn this study, we have evaluated the response of patients submitted to immunotherapy (IMT) with this combined vaccine together with multidrug therapy (MDT) during a 5- to lO-year period. Based on the use of multiple criteria, we have been able to analyze the diverse manifestations ofthe immune responses in these patients, most of whom had multibacillary disease. The parameters evaluated included determinations ofthe levels ofantibodies against PGLI, lymphocyte transformation assays, bacterial indexes and intradermal tests before each IMT treatment and at regular intervals for a period of at least 5 years.es_VE
dc.language.isoenes_VE
dc.publisherInternational Journal of Leprosy 62(4):552-558es_VE
dc.subjectImmunologic reactivityes_VE
dc.subjectleprosyes_VE
dc.subjectimmunotherapyes_VE
dc.titleA longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapyes_VE
dc.typeArticlees_VE
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Pub 1994.pdf218.14 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.